Finance

Beta
Lists
BIOE:OTCMKTS
Bio Essence Corp
$0.25
0.00%
(0.00) 1D
Jun 5, 3:12:51 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BIOE...
Mkt. cap
11.82M
Avg. vol.
1.26K
Volume
0.00
P/E ratio
7.53
52-wk high
$0.52
52-wk low
$0.05
EPS
$0.03
Beta
11.02
Shares outstanding
46.81M
No. of employees
4
Mkt. cap
11.82M
Avg. vol.
1.26K
Volume
0.00
P/E ratio
7.53
52-wk high
$0.52
52-wk low
$0.05
EPS
$0.03
Beta
11.02
Shares outstanding
46.81M
No. of employees
4
News stories
From sources across the web
About Bio Essence Corp
CEO-
Employees4
Founded2000
HeadquartersIrvine, California, United States
SectorPharmaceutical industry
Websitebioessencecorp.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
259.12K
136.80K
1.48M
500.54K
Cost of goods sold
90.48K
41.04K
336.03K
181.18K
Cost of revenue
90.48K
41.04K
336.03K
181.18K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
107.42K
81.51K
113.79K
103.56K
Operating expense
107.42K
81.51K
113.79K
103.56K
Total operating expenses
197.90K
122.55K
449.83K
284.74K
Operating income
61.22K
14.25K
1.03M
215.80K
Other non operating income
-12.00
-699.00
-
-41.00
EBT including unusual items
60.66K
13.00K
1.03M
215.21K
EBT excluding unusual items
60.66K
13.00K
1.03M
215.21K
Income tax expense
800.00
-
-
9.84K
Effective tax rate
1.32%
-
-
4.57%
Other operating expenses
-
-
-
-
Net income
59.86K
13.00K
1.03M
205.37K
Net profit margin
23.10%
9.50%
69.56%
41.03%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-547.00
-556.00
-540.00
-542.00
Net interest expenses
-547.00
-556.00
-540.00
-542.00
Depreciation and amortization charges
-
-
-
-
EBITDA
61.28K
14.31K
1.03M
215.85K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer